Treatment of secondary hyperparathyroidism in haemodialysis patients: a randomised clinical trial comparing paricalcitol and alfacalcidol

被引：0
|
作者：
Ditte Hansen
Lisbet Brandi
Knud Rasmussen
机构：
[1] Roskilde Hospital,Medical Department
[2] University of Copenhagen,Department of Surgery and Internal Medicine
来源：
BMC Nephrology | / 10卷
关键词：
Chronic Kidney Disease; Hypercalcemia; Vascular Calcification; Secondary Hyperparathyroidism; Alfacalcidol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Conversion of oral alfacalcidol to oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients
    Rauscher, Sandrine
    Lafrance, Jean-Philippe
    Pichette, Vincent
    Bell, Robert Z.
    Desforges, Katherine
    Lepage, Laurence
    Ouellet, Georges
    Ouimet, Denis
    Leblanc, Martine
    Lamarche, Caroline
    Bezzaoucha, Sarah
    Vallee, Michel
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2017, 49 (02) : 325 - 328
  • [42] Conversion of oral alfacalcidol to oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients
    Sandrine Rauscher
    Jean-Philippe Lafrance
    Vincent Pichette
    Robert Z Bell
    Katherine Desforges
    Laurence Lepage
    Georges Ouellet
    Denis Ouimet
    Martine Leblanc
    Caroline Lamarche
    Sarah Bezzaoucha
    Michel Vallee
    International Urology and Nephrology, 2017, 49 : 325 - 328
  • [43] Efficacy of alfacalcidol treatment for secondary hyperparathyroidism in patients with chronic renal failure before dialysis
    Rozhinskaya, L. Y.
    Il'ina, A. N.
    Borisov, A., V
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S247 - S248
  • [44] Experience of paricalcitol capsule for the treatment of secondary hyperparathyroidism in early stage CKD patients in Poland
    Sulowicz, W
    Qiu, P
    Mysliwiec, M
    Wankowicz, Z
    Hippensteel, R
    Williams, L
    Smolenski, O
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V88 - V88
  • [45] Paricalcitol in dialysis patients with calcitriol-resistant secondary hyperparathyroidism
    Llach, F
    Yudd, M
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (05) : S45 - S50
  • [46] Paricalcitol in hemodialysis patients with secondary hyperparathyroidism and its potential benefits
    Xiu Chen
    Feng Zhao
    Wei-Juan Pan
    Jia-Mei Di
    Wei-Nan Xie
    Ling Yuan
    Zhi Liu
    World Journal of Clinical Cases, 2021, (33) : 10172 - 10179
  • [47] Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis The J-DAVID Randomized Clinical Trial
    Shoji, Tetsuo
    Inaba, Masaaki
    Fukagawa, Masafumi
    Ando, Ryoichi
    Emoto, Masanori
    Fujii, Hisako
    Fujimori, Akira
    Fukui, Mitsuru
    Hase, Hiroki
    Hashimoto, Tetsuya
    Hirakata, Hideki
    Honda, Hirokazu
    Hosoya, Tatsuo
    Ikari, Yuji
    Inaguma, Daijo
    Inoue, Toru
    Isaka, Yoshitaka
    Iseki, Kunitoshi
    Ishimura, Eiji
    Itami, Noritomo
    Ito, Chiharu
    Kakuta, Toshitaka
    Kawai, Toru
    Kawanishi, Hideki
    Kobayashi, Shuzo
    Kumagai, Junko
    Maekawa, Kiyoshi
    Masakane, Ikuto
    Minakuchi, Jun
    Mitsuiki, Koji
    Mizuguchi, Takashi
    Morimoto, Satoshi
    Murohara, Toyoaki
    Nakatani, Tatsuya
    Negi, Shigeo
    Nishi, Shinichi
    Nishikawa, Mitsushige
    Ogawa, Tetsuya
    Ohta, Kazumichi
    Ohtake, Takayasu
    Okamura, Mikio
    Okuno, Senji
    Shigematsu, Takashi
    Sugimoto, Toshitsugu
    Suzuki, Masashi
    Tahara, Hideki
    Takemoto, Yoshiaki
    Tanaka, Kenji
    Tominaga, Yoshihiro
    Tsubakihara, Yoshiharu
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (22): : 2325 - 2334
  • [48] Paricalcitol in hemodialysis patients with secondary hyperparathyroidism and its potential benefits
    Chen, Xiu
    Zhao, Feng
    Pan, Wei-Juan
    Di, Jia-Mei
    Xie, Wei-Nan
    Yuan, Ling
    Liu, Zhi
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (33) : 10172 - 10179
  • [49] Effect of paricalcitol on biochemical markers of secondary hyperparathyroidism in hemodialysis patients
    Zdravkovic, J.
    Georgijev, D. Ristic
    Zdravkovic, A.
    Zdravkovic, K.
    Popovic, M.
    Stojanovic, S.
    CLINICA CHIMICA ACTA, 2024, 558
  • [50] Cost Effectiveness of Paricalcitol Versus Cinacalcet with Low-Dose Vitamin D for Management of Secondary Hyperparathyroidism in Haemodialysis Patients in the USA
    Amit Sharma
    Thomas S. Marshall
    Samina S. Khan
    Beverly Johns
    Clinical Drug Investigation, 2014, 34 : 107 - 115
12345